Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Adamas Pharmaceuticals Inc (ADMS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 2,700,000 $16,740 -2% 1.05%
2.
Broadfin Capital

Kevin Kotler

441,088 $2,735 -83% 0.59%
3.
Kerrisdale Capital

Sahm Adrangi

229,347 $1,422 +234% 0.5%
4.
PDT Partners

Peter Muller

78,200 $485 0.02%
5.
Granite Point Capital

Warren Lammert

54,822 $340 0.02%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$12.98 3,850 Officer, Director 199,242 2018-11-07 Filing
$16.81 8,240 Large Shareholder, Director 4,031,804 2016-09-16 Filing
$16.50 200 Large Shareholder, Director 4,023,564 2016-09-15 Filing
$16.43 54,537 Large Shareholder, Director 4,023,364 2016-09-14 Filing
$16.81 8,240 Large Shareholder 4,031,804 2016-09-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.91 1,584 Officer 48,019 2019-09-20 Filing
$6.00 1,082 Officer 47,209 2019-07-22 Filing
$5.35 940 Officer 63,114 2019-06-20 Filing
$7.99 857 Officer 24,603 2019-03-20 Filing
$8.00 2,374 Officer 19,141 2019-03-20 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 67,400 $345 0.08%
2. 0 $0 0%
3. 972 $5 0%
4. 313 $2 0%
5. 0 $0 0%
News See All